Inhibitory interneurons, oxidative stress, and schizophrenia

Schizophrenia Bulletin

Volumn 38, Issue 3, 2012, Pages 373-376

  Sullivan, Elyse M ^a   O'Donnell, Patricio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

adolescence; animal models; cognitive deficits; GABA; NMDA; parvalbumin

Indexed keywords

APOCYNIN; GLUTATHIONE; OMEGA 3 FATTY ACID;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; DRUG MECHANISM; EVOKED AUDITORY RESPONSE; INTERNEURON; MISMATCH NEGATIVITY; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

ANIMALS; HUMANS; NEURAL INHIBITION; OXIDATIVE STRESS; SCHIZOPHRENIA;

EID: 84860207571     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs052     Document Type: Article

References (30)

1. Cardin JA, Carlen M, Meletis K, et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009;459:663-667.
2. Traub RD, Pais I, Bibbig A, et al. Contrasting roles of axonal (pyramidal cell) and dendritic (interneuron) electrical coupling in the generation of neuronal network oscillations. Proc Natl Acad Sci USA. 2003;100:1370-1374. (Pubitemid 36184008)
3. Tseng KY, O'Donnell P. Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb Cortex. 2007;17:1235-1240. (Pubitemid 46598865)
4. Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459:698-702.
5. Uhlhaas PJ, Roux F, Singer W, Haenschel C, Sireteanu R, Rodriguez E. The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc Natl Acad Sci USA. 2009;106:9866-9871.
6. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005;6:312-324. (Pubitemid 40469985)
7. Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
8. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003;23:6315-6326. (Pubitemid 36875633)
9. Uhlhaas PJ, Haenschel C, Nikolic D, Singer W. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull. 2008;34:927-943.
10. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex. 2002;12:975-982.
11. Lodge DJ, Behrens MM, Grace AA. A loss of parvalbumincontaining interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009;29:2344-2354.
12. Wang CZ, Yang SF, Xia Y, Johnson KM. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology. 2008;33:2442-2455.
13. Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci. 2008;28:13957-13966.
14. Feleder C, Tseng KY, Calhoon GG, O'Donnell P. Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats. Biol Psychiatry. 2010;67:386-392.
15. Niwa M, Kamiya A, Murai R, et al. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron. 2010;65:480-489.
16. O'Donnell P. Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models. Schizophr Bull. 2011;37:484-492.
17. Behrens MM, Sejnowski TJ. Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology. 2009;57:193-200.
18. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009;19:220-230.
19. Do KQ, Trabesinger AH, Kirsten-Kruger M, et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci. 2000;12:3721-3728.
20. Yao JK, Leonard S, Reddy R. Altered glutathione redox state in schizophrenia. Dis Markers. 2006;22:83-93. (Pubitemid 41831607)
21. Steullet P, Cabungcal JH, Kulak A, et al. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci. 2010;30:2547-2558.
22. Powell SB, Sejnowski TJ, Behrens MM. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology. 2012;62:1322-1331.
23. O'Donnell P, Cabungcal JH, Piantadosi PT, Lewis E, Calhoon GG, Do KQ. Oxidative stress during development in prefrontal cortical interneurons in developmental animal models of schizophrenia. Schizophr Bull. 2011;37:111.
24. Behrens MM, Ali SS, Dao DN, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645-1647. (Pubitemid 350233667)
25. Berk M, Copolov D, Dean O, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64:361-368.
26. Lavoie S, Murray MM, Deppen P, et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology. 2008;33: 2187-2199. (Pubitemid 351992093)
27. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull. 2007;33:69-94. (Pubitemid 46026260)
28. Naatanen R, Paavilainen P, Reinikainen K. Do event-related potentials to infrequent decrements in duration of auditory stimuli demonstrate a memory trace in man? Neurosci Lett. 1989;107:347-352. (Pubitemid 20013262)
29. Amminger GP, Schafer MR, Papageorgiou K, et al. Longchain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67:146-154.
30. Berger GE, Wood SJ, Wellard RM, et al. Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology. 2008;33:2467-2473.